Leonard P. Freedman, PhD
Dr. Freedman is the founding President of GBSI. He has over 30 years of research, management, and program development experience in molecular and cell biology, biomedical research, and drug discovery in both the private sector and academia. Dr. Freedman is a recognized leader in the field of nuclear hormone receptors.
Prior to joining GBSI, Dr. Freedman served as Vice Dean for Research and Professor of Biochemistry and Molecular Biology at Jefferson Medical College, Thomas Jefferson University. Prior to his leadership role at Jefferson, Dr. Freedman led discovery research efforts in the pharmaceutical industry as a Vice President at Wyeth and Executive Director at Merck. Before moving to industry, Dr. Freedman was a Member and Professor of Cell Biology & Genetics at Memorial Sloan-Kettering Cancer Center and Weil Cornell Medical College.
Dr. Freedman has received several research awards, including the Boyer Research Award for Biomedical Research, and a MERIT award from the NIH. He was also the 2002 recipient of the Ernst Oppenheimer Award from The Endocrine Society. Dr. Freedman has published extensively and served on numerous scientific review panels and editorial boards. He was an editor of Molecular and Cellular Biology for ten years. In addition, Dr. Freedman has served on the Board of Directors of the American Type Culture Collection (ATCC).
Dr. Freedman earned a B.A. degree in Biology from Kalamazoo College, and a Ph.D. in Molecular Genetics from the University of Rochester. He completed his post-doctoral fellowship in the laboratory of Dr. Keith Yamamoto at the University of California, San Francisco.